Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 6:16 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Avidity Partners Management LP | 1,896,000 6% | 1,896,000 (New Position) | View |
| 2022-02-10 4:54 pm Sale | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | JANUS HENDERSON GROUP PLC JHG | 1,841,357 5.9% | -97,079 (-5.01%) | View |
| 2022-02-10 4:16 pm Sale | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Yamada Tadataka | 0 0% | -1,687,721 (Position Closed) | View |
| 2022-02-10 11:32 am Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Invesco Ltd. IVZ | 2,067,356 6.6% | 12,918 (+0.63%) | View |
| 2022-02-10 08:32 am Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | VANGUARD GROUP INC | 1,927,844 6.14% | 1,927,844 (New Position) | View |
| 2021-11-12 06:03 am Sale | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 7,459,304 19.2% | -1,212,696 (-13.98%) | View |
| 2021-04-06 06:05 am Unchanged | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 8,672,000 22.3% | 0 (Unchanged) | View |
| 2021-04-01 06:06 am Unchanged | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | TAKEDA PHARMACEUTICAL CO LTD TAK | 8,672,000 22.3% | 0 (Unchanged) | View |
| 2021-02-16 4:39 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | RA CAPITAL MANAGEMENT L.P. | 3,825,008 12.3% | 178,200 (+4.89%) | View |
| 2021-02-12 2:53 pm Sale | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Invesco Ltd. IVZ | 2,054,438 6.6% | -47,865 (-2.28%) | View |
| 2021-02-11 5:05 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | JANUS HENDERSON GROUP PLC JHG | 1,938,436 6.7% | 470,974 (+32.09%) | View |
| 2021-02-11 4:15 pm Sale | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Socks David A | 1,505,945 4.8% | -180,759 (-10.72%) | View |
| 2021-02-11 4:15 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Yamada Tadataka | 1,687,721 5.4% | 1,017 (+0.06%) | View |
| 2020-12-23 1:08 pm Unchanged | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences IX L.P. | 5,843,924 18.7% | 0 (Unchanged) | View |
| 2020-06-16 7:37 pm Sale | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences IX L.P. | 5,843,924 20.2% | -1,440,345 (-19.77%) | View |
| 2020-02-14 4:34 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | RA CAPITAL MANAGEMENT L.P. | 3,646,808 14.9% | 162 (+0.00%) | View |
| 2020-02-14 3:25 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | JANUS HENDERSON GROUP PLC JHG | 1,467,462 6% | 1,467,462 (New Position) | View |
| 2020-02-13 3:13 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Invesco Ltd. IVZ | 2,102,303 8.6% | 2,102,303 (New Position) | View |
| 2020-02-10 4:32 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Socks David A | 1,686,704 6.9% | 1,686,704 (New Position) | View |
| 2020-02-10 4:30 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | Yamada Tadataka | 1,686,704 6.9% | 1,686,704 (New Position) | View |